Market Cap 4.74B
Revenue (ttm) 1.10B
Net Income (ttm) 112.09M
EPS (ttm) N/A
PE Ratio 20.01
Forward PE 16.97
Profit Margin 10.20%
Debt to Equity Ratio 0.38
Volume 2,820,300
Avg Vol 2,706,880
Day's Range N/A - N/A
Shares Out 191.68M
Stochastic %K 31%
Beta 0.80
Analysts Strong Sell
Price Target $36.77

Company Profile

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.

Industry: Health Information Services
Sector: Healthcare
Phone: 844 492 9782
Address:
1550 Digital Drive, #300, Lehi, United States
ClarVal
ClarVal Mar. 8 at 3:03 AM
$WAY https://clarval.com/stock/WAY
0 · Reply
Jasooon
Jasooon Mar. 7 at 3:16 AM
$WAY this is criminally undervalued with the Google contract. Holy smokes, this is going to moon.
0 · Reply
Ro_Patel
Ro_Patel Mar. 5 at 6:27 PM
$WAY to expand its collab w/ $GOOGL Cloud to support the development of AI tools used in healthcare payment processing. Financial details of the collaboration expansion weren't provided The agreement will incorporate $GOOG Cloud infrastructure & its Gemini LLMs into Waystar's platform to support automation in revenue cycle operations The expanded relationship is expected to allow broader deployment of its technology across revenue cycle workflows & support faster development of new automated capabilities
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 5 at 2:05 PM
$WAY - Waystar Advances AI Innovation with Google Cloud to Accelerate the Autonomous Revenue Cycle
0 · Reply
ClarVal
ClarVal Mar. 5 at 9:50 AM
$WAY https://www.clarval.com/
0 · Reply
JeraldBatista974
JeraldBatista974 Feb. 21 at 8:02 AM
$WAY Waystar provides healthcare revenue cycle management software. Growth depends on provider adoption. Margins improve with scale.
0 · Reply
erevnon
erevnon Feb. 18 at 6:02 PM
Goldman Sachs maintains Waystar Holding $WAY at Buy and lowers the price target from $44 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
OwletnightjarPartners
OwletnightjarPartners Feb. 18 at 4:18 PM
$WAY Waystar offers healthcare revenue cycle management software. Adoption depends on provider efficiency needs. Margin expansion improves with scale.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 18 at 1:13 PM
$WAY Share Price: $24.33 Contract Selected: Sep 18, 2026 $25 Calls Buy Zone: $3.14 – $3.87 Target Zone: $5.59 – $6.83 Potential Upside: 68% ROI Time to Expiration: 211 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Stackdoe101
Stackdoe101 Feb. 17 at 8:58 PM
0 · Reply
Latest News on WAY
Waystar: Upside Remains Very Attractive

Mar 3, 2026, 3:19 PM EST - 15 days ago

Waystar: Upside Remains Very Attractive


These Analysts Cut Their Forecasts On Waystar After Q4 Results

Feb 18, 2026, 1:16 PM EST - 4 weeks ago

These Analysts Cut Their Forecasts On Waystar After Q4 Results


Waystar Holding Corp. (WAY) Q4 2025 Earnings Call Transcript

Feb 17, 2026, 1:44 PM EST - 4 weeks ago

Waystar Holding Corp. (WAY) Q4 2025 Earnings Call Transcript


Waystar Recognized as Inc. Best in Business for AI

Feb 16, 2026, 9:00 AM EST - 4 weeks ago

Waystar Recognized as Inc. Best in Business for AI


Waystar Earns Continued Best in KLAS Honors

Feb 4, 2026, 9:26 AM EST - 6 weeks ago

Waystar Earns Continued Best in KLAS Honors


Waystar to Present at J.P. Morgan Healthcare Conference

Dec 29, 2025, 9:00 AM EST - 2 months ago

Waystar to Present at J.P. Morgan Healthcare Conference


Waystar to Participate in Upcoming Investor Conferences

Nov 18, 2025, 9:00 AM EST - 4 months ago

Waystar to Participate in Upcoming Investor Conferences


Waystar Holding Corp. (WAY) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 7:46 PM EDT - 5 months ago

Waystar Holding Corp. (WAY) Q3 2025 Earnings Call Transcript


Waystar Reports Third Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 5 months ago

Waystar Reports Third Quarter 2025 Results


Waystar Joins S&P SmallCap 600 Index

Sep 22, 2025, 8:15 AM EDT - 6 months ago

Waystar Joins S&P SmallCap 600 Index


Waystar Announces Pricing of Secondary Offering of Common Stock

Sep 11, 2025, 8:30 AM EDT - 6 months ago

Waystar Announces Pricing of Secondary Offering of Common Stock


Waystar Announces Launch of Secondary Offering of Common Stock

Sep 10, 2025, 4:43 PM EDT - 6 months ago

Waystar Announces Launch of Secondary Offering of Common Stock


Waystar Enhances Financial Flexibility with Term Loan Repricing

Aug 12, 2025, 4:34 PM EDT - 7 months ago

Waystar Enhances Financial Flexibility with Term Loan Repricing


The Best Small-Cap Stocks to Buy Now

Aug 12, 2025, 9:47 AM EDT - 7 months ago

The Best Small-Cap Stocks to Buy Now

DNLI KYMR


Waystar Posts Impressive Q2 Numbers: Why I Maintain A Buy Rating

Aug 10, 2025, 8:41 AM EDT - 7 months ago

Waystar Posts Impressive Q2 Numbers: Why I Maintain A Buy Rating


Waystar Holding Corp. (WAY) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:46 PM EDT - 8 months ago

Waystar Holding Corp. (WAY) Q2 2025 Earnings Call Transcript


Waystar Reports Second Quarter 2025 Results

Jul 30, 2025, 4:05 PM EDT - 8 months ago

Waystar Reports Second Quarter 2025 Results


AI-Focused Waystar, Iodine Deal Wins Praise For Margin Upside

Jul 24, 2025, 10:59 AM EDT - 8 months ago

AI-Focused Waystar, Iodine Deal Wins Praise For Margin Upside


Waystar Nears Deal for Iodine Software

Jul 23, 2025, 4:00 PM EDT - 8 months ago

Waystar Nears Deal for Iodine Software


Waystar Q1 Review: Navigating Premium Valuation With A View To Buy

May 25, 2025, 5:42 AM EDT - 10 months ago

Waystar Q1 Review: Navigating Premium Valuation With A View To Buy


Waystar Announces Pricing of Public Offering of Common Stock

May 14, 2025, 7:30 PM EDT - 11 months ago

Waystar Announces Pricing of Public Offering of Common Stock


Waystar Announces Proposed Public Offering of Common Stock

May 13, 2025, 8:57 AM EDT - 11 months ago

Waystar Announces Proposed Public Offering of Common Stock


ClarVal
ClarVal Mar. 8 at 3:03 AM
$WAY https://clarval.com/stock/WAY
0 · Reply
Jasooon
Jasooon Mar. 7 at 3:16 AM
$WAY this is criminally undervalued with the Google contract. Holy smokes, this is going to moon.
0 · Reply
Ro_Patel
Ro_Patel Mar. 5 at 6:27 PM
$WAY to expand its collab w/ $GOOGL Cloud to support the development of AI tools used in healthcare payment processing. Financial details of the collaboration expansion weren't provided The agreement will incorporate $GOOG Cloud infrastructure & its Gemini LLMs into Waystar's platform to support automation in revenue cycle operations The expanded relationship is expected to allow broader deployment of its technology across revenue cycle workflows & support faster development of new automated capabilities
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 5 at 2:05 PM
$WAY - Waystar Advances AI Innovation with Google Cloud to Accelerate the Autonomous Revenue Cycle
0 · Reply
ClarVal
ClarVal Mar. 5 at 9:50 AM
$WAY https://www.clarval.com/
0 · Reply
JeraldBatista974
JeraldBatista974 Feb. 21 at 8:02 AM
$WAY Waystar provides healthcare revenue cycle management software. Growth depends on provider adoption. Margins improve with scale.
0 · Reply
erevnon
erevnon Feb. 18 at 6:02 PM
Goldman Sachs maintains Waystar Holding $WAY at Buy and lowers the price target from $44 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
OwletnightjarPartners
OwletnightjarPartners Feb. 18 at 4:18 PM
$WAY Waystar offers healthcare revenue cycle management software. Adoption depends on provider efficiency needs. Margin expansion improves with scale.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 18 at 1:13 PM
$WAY Share Price: $24.33 Contract Selected: Sep 18, 2026 $25 Calls Buy Zone: $3.14 – $3.87 Target Zone: $5.59 – $6.83 Potential Upside: 68% ROI Time to Expiration: 211 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Stackdoe101
Stackdoe101 Feb. 17 at 8:58 PM
0 · Reply
d_risk
d_risk Feb. 17 at 4:45 PM
$WAY - Waystar Holding Corp - 10K - Updated Risk Factors WAY’s 10-K risk revamp leans hard into competitive and regulatory pressure: sharper warnings on big-tech and EHR rivals, execution and M&A integration, AI-related product, IP and cyber risks, heavier third‑party and data‑privacy exposure, growing leverage and goodwill impairments, and expanded stock, governance, and macro/geopolitical overhangs. #HealthTech #RegulatoryRisk #MergersIntegration #AIRisk #DataPrivacy 🟢 Added 🟠 Removed https://d-risk.ai/WAY/10-K/2026-02-17
1 · Reply
matthew2000_2
matthew2000_2 Feb. 17 at 4:25 PM
$WAY back in the green
0 · Reply
sandwraith025th
sandwraith025th Feb. 17 at 4:18 PM
0 · Reply
phantomtrader75
phantomtrader75 Feb. 17 at 3:40 PM
$WAY WTF
0 · Reply
sandwraith025th
sandwraith025th Feb. 17 at 3:05 PM
$WAY 40
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 17 at 1:55 PM
$WAY (+6.0% pre) Waystar Holding Corp. (WAY) Reports Q4 EPS of $0.36 ; Offers Guidance https://ooc.bz/l/93527
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 1:25 PM
$WAY Current Stock Price: $22.42 Contracts to trade: $22.5 WAY Feb 20 2026 Call Entry: $1.53 Exit: $2.58 ROI: 69% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 17 at 11:53 AM
$WAY Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.10 down -9.09% YoY • Reported revenue of $303.54M up 24.35% YoY
0 · Reply
david102
david102 Feb. 14 at 1:16 PM
$WAY WAY “fits” as the company selling the robot’s capabilities, benefiting from the operational mess, but still exposed to customers tightening budgets.
0 · Reply
matthew2000_2
matthew2000_2 Feb. 13 at 12:29 AM
$WAY undervalued stock that I think will squeeze with earnings. Other healthcare stocks have been doing poorly since medical spending is cutting back and denials are more common, but that’s bullish for Waystar which helps companies deal with complex healthcare issues, and helps them collect money.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 12 at 11:51 AM
$WAY Share Price: $23.73 Contract Selected: Sep 18, 2026 $20 Calls Buy Zone: $4.53 – $5.59 Target Zone: $7.43 – $9.08 Potential Upside: 55% ROI Time to Expiration: 217 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Kalle1
Kalle1 Feb. 10 at 11:18 AM
$WAY why is this stock going down this much when the company performs so well?
1 · Reply